Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-19674
Publication type: Working paper – expertise – study
Title: Biosimilars in der Schweiz : Medizin gegen die steigenden Gesundheitskosten?
Authors: Kobler, Irene
Lenzin, Golda
Liberatore, Florian
Pöhlmann, Johannes
Schmidt, Marion
Wieser, Simon
et. al: No
DOI: 10.21256/zhaw-19674
Extent: 78
Issue Date: Mar-2020
Publisher / Ed. Institution: ZHAW Zürcher Hochschule für Angewandte Wissenschaften
Publisher / Ed. Institution: Winterthur
Language: German
Subjects: Biosimilars; Gesundheitskosten; Gesundheitspolitik Schweiz
Subject (DDC): 362: Health and social services
615: Pharmacology and therapeutics
URI: https://digitalcollection.zhaw.ch/handle/11475/19674
License (according to publishing contract): CC BY 4.0: Attribution 4.0 International
Departement: School of Management and Law
Organisational Unit: Winterthur Institute of Health Economics (WIG)
Appears in Collections:Gesundheitsökonomie

Files in This Item:
File Description SizeFormat 
2020_Kobler_Biosimilars_in_der_Schweiz_ZHAW.pdf2.02 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.